Biogen Inc (BIIB) stock news · P/E 21, rev $9.89B
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ. It is led by Christopher A. Viehbacher.
This BIIB news page leads with what Biogen Inc filed — not a scraped headline mill.
No cached 8-K sentence for BIIB yet. We will not pad this page with generic market recap.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the BIIB stock page; for the tape open the quote page.
Not investment advice.